Archive for 'October,2012'

100th spin-off of the University of Liège, SYNOLYNE SA (Liège, Belgium), develops patented chitosan-based hydrogel to wipe out arthritis.

100th spin-off of the University of Liège, SYNOLYNE SA (Liège, Belgium), develops patented chitosan-based hydrogel to wipe out arthritis.

SYNOLYNE SA, the new spin-off of Liège University and spin-out of Kitozyme SA, is specialized in the research, development and marketing of a chitosan-based hydrogel with mechanical and biological properties designed to protect the cartilage and [...]

Delphi Genetics (Gosselies, Belgium) closes a deal granting Merck –MSD broad-based licensing for the use of the StabyExpress™ system.

Delphi Genetics (Gosselies, Belgium) closes a deal granting Merck –MSD broad-based licensing for the use of the StabyExpress™ system.

Delphi Genetics SA (“Delphi”) has recently sealed a deal with MSD, a subsidiary of Merck & Co (New Jersey, USA) granting a broad-based licensing agreement for the use of the StabyExpress™ technology. The innovative technology offers [...]

Janssen Pharmaceutica expanding in Wallonia (La Louvière, Belgium) with opening of new European center dedicated to pharmaceutical drugs distribution.

Janssen Pharmaceutica expanding in Wallonia (La Louvière, Belgium) with opening of new European center dedicated to pharmaceutical drugs distribution.

Janssen Pharmaceutica is broadening its presence in Wallonia with the opening of a new European center dedicated to the distribution of pharmaceutical products. A company specializing in a wide range of areas, such as neurosciences, oncology [...]

Euroscreen(Gosselies,Belgium): selling “Euroscreen FAST” to focus on state-of-the-art small molecule drug therapeutics

Euroscreen(Gosselies,Belgium): selling “Euroscreen FAST” to focus on state-of-the-art small molecule drug therapeutics

Euroscreen, a spin-off of ULB with plans of establishing a treatment for endometriosis*, is putting its “services business unit” up for sale. Recognizing the need for capital increases like the other active companies in the biotechnologies [...]